Research progress on metabolism-related biomarkers of frailty in the elderly

Abstract

Abstract: Frailty is a common syndrome in the elderly, identified by the decline of physiological functions in multiple organ systems, which may lead to adverse outcomes such as falls, cognitive impairment, hospitalization or death. Early diagnosis of frailty is of great value in promoting healthy aging. At present, it can only be diagnosed by assessment tools in clinical without specific biomarkers. Frailty is often accompanied by metabolic disorders in many aspects, such as changes in metabolism of energy, muscle, bone, and in endocrine system. The study of metabolism-related biomarkers can help early diagnosis and intervention of frailty.

Key words: frailty, metabolism, biomarkers, diagnose, elderly

CLC Number:

PAN Yi-ming, LI Yun, MA Li-na. Research progress on metabolism-related biomarkers of frailty in the elderly[J]. Basic & Clinical Medicine, 2021, 41(3): 428-432.

References

[1] Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sc, 2001, 56: M146-M157.
[2] Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging[J]. Sci World J, 2001, 1: 323-336.
[3] Xu W, Li Y, Wu C. Incidence of frailty among community-dwelling older adults: a nationally representative profile in China[J]. Bmc Geriatr,2019, 19: 378. doi: 10.1186/s12877-019-1393-7.
[4] Lana A, Valdés-Bécares A, Buño A, et al. Serum leptin concentration is associated with incident frailty in older adults[J]. Aging Dis,2017, 8: 240-249.
[5] Waters DL, Vlietstra L, Qualls C, et al. Sex-specific muscle and metabolic biomarkers associated with gait speed and cognitive transitions in older adults: a 9-year follow-up[J]. Geroscience, 2020, 42: 585-593.
[6] Nagasawa M, Takami Y, Akasaka H, et al. High plasma adiponectin levels are associated with frailty in a general old-old population: the septuagenarians, octogenarians, nonagenarians investigation with centenarians study[J]. Geriatr Gerontol Int,2018, 18: 839-846.
[7] Ma L, Sha G, Zhang Y, et al. Elevated serum Ⅱ-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults[J]. Clin Interv Aging,2018, 13: 2013-2020.
[8] Sanz B, Arrieta H, Hervás G, et al. Serum adiponectin is associated with body composition and cognitive and psychological status in older adults living in long-term nursing homes[J]. Exp Gerontol, 2019, 121: 1-9.
[9] De Breucker S, Luce S, Njemini R, et al. Analysis of inflammatory markers and hormones in old cancer patients: A descriptive study[J]. Exp Gerontol,2020, 130: 110787. doi: 10.1016/j.exger.2019.110787.
[10] Westbrook RM, Yang HL, Langdon JM, et al. Aged interleukin-10tm1Cgn chronically inflamed mice have substantially reduced fat mass, metabolic rate, and adipo-kines[J]. PLoS One, 2017, 12: e186811. doi: 10.1371/journal.pone.0186811.
[11] Kochlik B, Stuetz W, Pérès K, et al. Associations of plasma 3-methylhistidine with frailty status in french cohorts of the FRAILOMIC initiative[J]. J Clin Med, 2019, 8: 1010. doi: 10.3390/jcm8071010.
[12] Coelho-Junior HJ, Picca A, Calvani R, et al. If my muscle could talk: myokines as a biomarker of frailty[J]. Exp Gerontol, 2019, 127: 110715. doi: 10.1016/j.exger.2019.110715.
[13] Berry SD, Ramachandran VS, Cawthon PM, et al. Procollagen type Ⅲ N-terminal peptide (P3NP) and lean mass: a cross-sectional study[J]. J Frailty Aging, 2013, 2: 129-134.
[14] Abreu EL, Cheng A, Kelly PJ, et al. Skeletal muscle troponin as a novel biomarker to enhance assessment of the impact of strength training on fall prevention in the older adults[J]. Nurs Res, 2014, 63: 75-82.
[15] Watanabe S, Sato K, Hasegawa N, et al. Serum C1q as a novel biomarker of sarcopenia in older adults[J]. FASEB J, 2015, 29: 1003-1010.
[16] Chew J, Tay L, Lim JP, et al. Serum myostatin and IGF-1 as gender-specific biomarkers of frailty and low muscle mass in community-dwelling older adults[J]. J Nutr Health Aging,2019, 23: 979-986.
[17] Arrieta H, Hervás G, Rezola-Pardo C, et al. Serum myostatin levels are higher in fitter, more active, and non-frail long-term nursing home residents and increase after a physical exercise intervention[J]. Gerontology, 2019, 65: 229-239.
[18] Puts MTE, Visser M, Twisk JWR, et al. Endocrine and inflammatory markers as predictors of frailty[J]. Clin Endocrinol,2005, 63: 403-411.
[19] Alvarez-Ríos AI, Guerrero JM, García-García FJ, et al. Associations between frailty and serum N-terminal propeptide of type I procollagen and 25-hydroxyvitamin D in older Spanish women: the toledo study for healthy aging[J]. Exp Gerontol,2015, 69: 79-84.
[20] Jayanama K, Theou O, Blodgett JM, et al. Frailty, nutrition-related parameters, and mortality across the adult age spectrum[J]. Bmc Med, 2018, 16: 188. doi: 10.1186/s12916-018-1176-6.
[21] Valentini A, Cianfarani MA, Tarantino U, et al. Osteoprotegerin as a biomarker of geriatric frailty syndrome[J]. Aging, 2019, 11: 4900-4909.
[22] Gunawardene P, Bermeo S, Vidal C, et al. Association between circulating osteogenic progenitor cells and disability and frailty in older persons: the nepean osteoporosis and frailty study[J]. J Gerontol A Biol Sci Med Sci, 2016, 71: 1124-1130.
[23] Varadhan R, Walston J, Cappola AR, et al. Higher levels and blunted diurnal variation of cortisol in frail older women[J]. J Gerontol A Biol Sci Med Sci, 2008, 63: 190-195.
[24] Johar H, Emeny RT, Bidlingmaier M, et al. Blunted diurnal cortisol pattern is associated with frailty: a cross-sectional study of 745 participants aged 65 to 90 years[J]. J Clin Endocrinol Metab, 2014, 99: E464-E468.
[25] Marcos-Pérez D, Sánchez-Flores M, Maseda A, et al. Serum cortisol but not oxidative stress biomarkers are related to frailty: results of a cross-sectional study in Spanish older adults[J]. J Toxicol Environ Health A, 2019, 82: 815-825.
[26] Baylis D, Bartlett DB, Syddall HE, et al. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people[J]. Age, 2013, 35: 963-971.